ANALYSIS OF TRENDS IN THE REIMBURSEMENT PROGRAM "AFFORDABLE MEDICINES" IN UKRAINE

Authors

DOI:

https://doi.org/10.11603/2312-0967.2021.4.12658

Keywords:

reimbursement, cardiovascular diseases, e-prescriptions, Affordable medicine»

Abstract

The aim of the work. To analyze the implementation of the goverment reimbursement program "Affordable Medicines" for outpatient treatment of essential medicines for patients with cardiovascular disease, type II diabetes and asthma in 2019–2020.

Materials and Methods. The study objects were data from e-dashboards of the National Health Service of Ukraine, which were first implemented with the support of the Ministry of Health during 2019–2020; the content of Resolutions of the Cabinet of Ministers of Ukraine and Orders of the Ministry of Health of Ukraine, respectively. We used methods: frequency analysis, comparative analysis, logical and systematic content analysis.

Results and Discussion. We developed a method of analysis of reimbursement program, taking into account zoning of the territory of Ukraine in 5 macroregions and analyzed the following indicators: budget funding of the program; the number of prescribed and repaid e-prescriptions from April 1, 2019; distribution of e-prescriptions in the program by age and gender of patients; structure of pharmacies by form of ownership and type of settlement.

It was found that the amount of budget funding for the "Affordable Medicines" program in 2020 increased 3 times compared to 2017. The number of pharmacies in 2020 increased 1.84 times compared to the start of the program. Most of involved in the program pharmacies are located in the cities of the Western and Central macroregions. During 2019–2020 more than 50 % of e-prescriptions were prescribed for these INNs: bisoprolol, clopidogrel, enalapril and amlodipine.

Conclusions. The analysis of the reimbursement program revealed an increase in the number of pharmacies by 1.84 times compared to the start of the program in 2017. According to the regional distribution and analysis of indicators, the highest growth rates are found in the Southern macroregion. During the study period, more than 50 % of all e-prescriptions for the treatment of hypertension were prescribed for medicines such as bisoprolol, clopidogrel, enalapril and amlodipine.

Author Biographies

V. S. Huz , Danylo Halytsky Lviv National Medical University

PhD-student, Assistant of the Department of Management and Economy, Drug Technology and Pharmacoeconomics of Postgraduate Faculty

Olha, Danylo Halytsky Lviv National Medical University

DSc (Pharmacy), Professor, Head of the Department of Management and Economy, Drug Technology and Pharmacoeconomics of Postgraduate Faculty

N. M. Maksymovych , Danylo Halytsky Lviv National Medical University

PhD (Pharmacy), Associate Professor of the Department of Management and Economy, Drug Technology and Pharmacoeconomics of Postgraduate Faculty

References

Cardiovascular disease. Data and statistics. World Health Organization Europe [Internet]. [cited 2021 November 15]. Available from: https://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics.

The top 10 causes of death. World Health Organization [Internet]. [cited 2021 November 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

Roth G.A., Mensah G.A., Johnson C.O. et all Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. Journal of the American College of Cardiology [Internet]. 2020 December. [cited 2021 November 15]. doi: 10.1016/j.jacc.2020.11.010.

Resolution of the Cabinet of Ministers of Ukraine dated April, 25, 2012 № 340 «On the implementation of the pilot project on introduction of state regulation of prices of medicines to treat people with hypertension» [Internet]. [cited 2021 November 18] Available from: https://zakon.rada.gov.ua/laws/show/340-2012-%D0%BF#Text.

National Health Service of Ukraine (NHSU) [Internet]. [cited 2021 November 18] Available from: https://nszu.gov.ua/.

Order of the Ministry of Health of Ukraine dated January 21, 2019 No. 148 "On approval of the Register of medicines to reimbursement" [Internet]. [cited 2021 November 18] Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-21012019--148-pro-zatverdzhennja-reestru-likarskih-zasobiv-vartist-jakih-pidljagae-vidshkoduvannju-stanom-na-21-sichnja-2019-roku.

Order of the Ministry of Health of Ukraine dated July 30, 2019 No. 1715 "On approval of the Register of medicines to reimbursement" [Internet]. [cited 2021 November 18] Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-30072019--1715-pro-zatverdzhennja-reestru-likarskih-zasobiv-jaki-pidljagajut-reimbursacii-stanom-na-29-lipnja-2019-roku.

Order of the Ministry of Health of Ukraine dated February 13, 2020 No. 316 "On approval of the Register of medicines to reimbursement" [Internet]. [cited 2021 November 18] Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-13022020--316-pro-zatverdzhennja-reestru-likarskih-zasobiv-jaki-pidljagajut-reimbursacii-stanom-na-07-ljutogo-2020-roku.

Order of the Ministry of Health of Ukraine dated June 01, 2020 dated No. 1284 "On approval of the Register of medicines to reimbursement" [Internet]. [cited 2021 November 18] Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-01062020--1284-pro-zatverdzhennja-reestru-likarskih-zasobiv-jaki-pidljagajut-reimbursacii-stanom-na-28-travnja-2020-roku.

Order of the Ministry of Health of Ukraine dated August 07, 2020 No. 1851 "On approval of the Register of medicines to reimbursement" [Internet]. [cited 2021 November 18] Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-11082020--1851-pro-zatverdzhennja-reestru-likarskih-zasobiv-jaki-pidljagajut-reimbursacii-stanom-na-07-serpnja-2020-roku.

Chmyrova L., Fediai N. Zoning of the territory of Ukraine as one of the factors of spatial socio-economic development of regions. Efektyvna ekonomika [Internet]. 2013 [cited 2021 November 10]; № 3. Available from: http://www.economy.nayka.com.ua/?op=1&z=1878.

Huz V. S., Zaliska O. M., Maksymovych N. M. Retrospective analysis of prescriptions for the treatment of cardiovascular diseases in the program «Affordable medicines» on the example of a pharmacy. Farm. Zhurnal. 2020;(3):69-79. doi: 10.32352/0367-3057.3.19.03.

Dedet G., Polton D., Zimmermann N. et all. Evaluation of the "Affordable Medicines" programme in Ukraine [Internet]. report WHO Regional office for Europe; 2019 [cited 2021 November 18] Available from: https://www.euro.who.int/__data/assets/pdf_file/0019/400429/52308-WHO-Affordable-Medicines-Programme-Ukraine-UKR_low_V7.pdf.

Kostiuk I. Analysis of dynamics of the medcine list in the government program «Affordable Medicines» for treatment of bronchial asthma]. Farm. Zhurnal. 2019; 74(5):12-20. doi: 10.32352/0367-3057.5.19.02.

Symonenko N., Podgaina M., Nemchenko A. et al. Analysis of separate groups of cardiac drugs’ economics affordability in Ukraine in 2016–2020. Pharmaceutical Review / Farmacevtičnij časopis. 2021; 2(58):79–86. doi: 10.11603/2312-0967.2021.2.12183

Published

2022-02-17

How to Cite

Huz , V. S., Olha, & Maksymovych , N. M. (2022). ANALYSIS OF TRENDS IN THE REIMBURSEMENT PROGRAM "AFFORDABLE MEDICINES" IN UKRAINE. Pharmaceutical Review Farmacevtičnij časopis, (4), 53–62. https://doi.org/10.11603/2312-0967.2021.4.12658

Issue

Section

Pharmacoeconomics